Cita APA (7a ed.)

Kocher, H. M., Basu, B., Froeling, F. E. M., Sarker, D., Slater, S., Carlin, D., . . . Propper, D. J. (2020). Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer. Nature Portfolio.

Cita Chicago Style (17a ed.)

Kocher, Hemant M., et al. Phase I Clinical Trial Repurposing All-trans Retinoic Acid as a Stromal Targeting Agent for Pancreatic Cancer. Nature Portfolio, 2020.

Cita MLA (8a ed.)

Kocher, Hemant M., et al. Phase I Clinical Trial Repurposing All-trans Retinoic Acid as a Stromal Targeting Agent for Pancreatic Cancer. Nature Portfolio, 2020.